HealthCareEquipment.org


Status: In Stock

CONTAK RENEWAL CONTAK RENEWAL 3


A Cardiac Resynchronization Therapy Defibrillator (CRT-D) Related Image

(Not Necessarily related to the device)

Description:

CONTAK RENEWAL CONTAK RENEWAL 3 by Boston Scientific Corp.

The CONTAK RENEWAL by Boston Scientific Corp. is an advanced Cardiac Resynchronization Therapy Defibrillator (CRT-D). It's a technologically progressive device that stands at the forefront of medical equipment used for cardiac care.
The CONTAK RENEWAL 3 is specifically designed to manage heart rhythms and reduce the risk of sudden cardiac arrest, a critical healthcare challenge faced by many patients with heart failure.

The exceptional benefits of the CONTAK RENEWAL 3 lie in its unique capabilities to both resynchronize the beating of the patient’s heart and garner the life-saving power of a defibrillator. This dual function makes it a reliable solution for patients suffering from heart failure with a reduced ejection fraction who are at risk for sudden cardiac arrest.

Its adaptive circuit technology allows personalized therapy and advanced energy management, ensuring the optimum performance and longevity of the device. Additionally, the CONTAK Renewal features Greenlight™ Confirmation - a proprietary safety system designed to provide an added layer of protection.

In sum, the CONTAK RENEWAL 3 serves as a leading-edge solution providing personalized cardiac care, giving clinicians an impactful tool, and patients a safer path towards recovery.


Primary Use:

Main Medical Use of CONTAK RENEWAL/CONTAK RENEWAL 3


CONTAK RENEWAL and CONTAK RENEWAL 3 belong to a class of medical devices known as Cardiac Resynchronization Therapy Defibrillators (CRT-Ds). These sophisticated devices primarily serve to manage and improve abnormal heart rhythms, or arrhythmias, in patients suffering from certain types of heart disease.

Principle of Operation
In the heart, electrical signals regulate the beating or rhythm. However, in certain heart disease conditions, these electrical signals can become irregular, leading to inconsistent and inefficient heart beating. The CONTAK RENEWAL and CONTAK RENEWAL 3 devices are intended to correct this situation.

These devices are set to continuously mo


How It Works:

Introduction to the CONTAK RENEWAL CONTAK RENEWAL 3

The CONTAK RENEWAL CONTAK RENEWAL 3 is a top-tier Cardiac Rhythm Management Device. Purpose-built by leading medical engineers, it aims to provide life-saving technology to those suffering from certain cardiac health conditions, such as heart failure.

Function of the CONTAK RENEWAL CONTAK RENEWAL 3

The principle functionality of the CONTAK RENEWAL CONTAK RENEWAL 3 is to monitor, manage, and correct the rhythm of the heart. This is achieved through a combination of sensing and pacing capabilities designed to work in harmony with the organ's intrinsic rhythm. The device is implanted subcutaneously, positioned close to the heart. The CONTAK RENEWAL CONTAK RENEWAL 3 can detect disturbances in the heart’s rhythm, known as arrhythmias, that can be fatal if not promptly regulated. When the device recognizes an arrhythmia, it deploys an electrical pacing pulse. This pulse stimulates the heart to beat at a normal, healthy rhythm, effectively correcting the detected irregularity. The CONTAK RENEWAL CONTAK RENEWAL 3 can also provide what is referred to as Cardiac Resynchronization Therapy (CRT). This therapy ensures that various chambers of the heart beat at the same time, improving the heart's efficiency in pumping blood throughout the body. To adapt to fluctuations in the patient's daily physical activity and ongoing cardiac needs, the device uses a rate-responsive technology. This sophisticated technology continually adjusts the pacing rate in response to signals from the body, such as stress or exercise.

Conclusion

The CONTAK RENEWAL CONTAK RENEWAL 3 is a revolutionary Cardiac Rhythm Management Device that empowers patients with critical heart conditions to live healthier, more normal lives. Groundbreaking features like real-time arrhythmia detection and regulation, Cardiac Resynchronization Therapy (CRT), rate-responsive technology, and intrinsic cardiac conditioning make it a worthwhile investment in cardiac health. Its state-of-the-art technology and unmatched functionality underscore why it is an exceptional choice for patients and medical practitioners alike.

Manufacturer:

Boston Scientific Corp.


Status: In Stock


Are you the owner or manufacturer of this device? Need to update anything on this page or get in touch with us? Click here.

×

Owner/Manufacturer Registration

Thank you for your submission!

We will get in touch with you shortly.